CognaEducacao SA (COGNY) reports significant cash flow growth and student base expansion, despite facing revenue and margin pressures due to program delays.
These findings, alongside the linked systematic review and meta-analysis of antiviral treatment efficacy, supported the 2024 WHO guidelines expansion of treatment criteria to include individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results